B. Schwerer
- Neurology top 10%
- Peripheral Neuropathies and Disorders 9
-
- Hereditary Neurological Disorders 9
- Nerve injury and regeneration 3
- Infectious Diseases top 10%
- Leprosy Research and Treatment 6
-
- Mycobacterium research and diagnosis 6
-
- Glycosylation and Glycoproteins Research 3
-
- Chronic Lymphocytic Leukemia Research 3
-
- Pharmacological Effects of Natural Compounds 3
B. Schwerer
24 papers receiving 412 citations
Peers
Comparison fields: 5 of 65
- Neurology 163
- Cellular and Molecular Neuroscience 128
- Infectious Diseases 121
- Immunology 103
- Endocrinology 13
Countries citing papers authored by B. Schwerer
This map shows the geographic impact of B. Schwerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Schwerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Schwerer more than expected).
Fields of papers citing papers by B. Schwerer
This network shows the impact of papers produced by B. Schwerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Schwerer. The network helps show where B. Schwerer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside B. Schwerer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 45 | |
| 2 | 2000 | 24 | |
| 3 | Cerebrospinal fluid filtration and immunoglobulins in multifocal motor neuropathy. | 1999 | 8 |
| 4 | 1998 | 6 | |
| 5 | 1997 | 40 | |
| 6 | 1995 | 1 | |
| 7 | 1995 | 33 | |
| 8 | GM 1 antibodies in Guillain-Barré syndrome: isotypes, course and clinical outcome. | 1994 | 4 |
| 9 | 1992 | 32 | |
| 10 | Serum IgA1 and IgM antibodies against Mycobacterium leprae-derived phenolic glycolipid-I: a comparative study in leprosy patients and their contacts. | 1991 | 9 |
| 11 | Serum antibodies against peripheral nervous system antigens in leprosy. | 1991 | 3 |
| 12 | 1989 | 6 | |
| 13 | 1987 | 37 | |
| 14 | 1986 | 40 | |
| 15 | IgM antibodies against phenolic glycolipid I from Mycobacterium leprae in leprosy sera: relationship to bacterial index and erythema nodosum leprosum. | 1985 | 16 |
| 16 | Antibodies in the pathogenesis of demyelination in chronic relapsing EAE (cr-EAE). | 1984 | 12 |
| 17 | 1984 | 28 | |
| 18 | 1983 | 16 | |
| 19 | 1982 | 5 | |
| 20 | 1981 | 4 |
About B. Schwerer
B. Schwerer is a scholar working on Neurology, Cellular and Molecular Neuroscience and Infectious Diseases, having authored 24 papers that have together received 431 indexed citations. Recurring topics across this work include Peripheral Neuropathies and Disorders (9 papers), Hereditary Neurological Disorders (9 papers), Leprosy Research and Treatment (6 papers), Mycobacterium research and diagnosis (6 papers), Glycosylation and Glycoproteins Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Pharmacological Effects of Natural Compounds (3 papers) and Nerve injury and regeneration (3 papers). The work is most often cited by research in Neurology (163 citations), Cellular and Molecular Neuroscience (128 citations) and Infectious Diseases (121 citations). B. Schwerer has collaborated with scholars based in Austria, United States and Ireland. Frequent co-authors include H. Bernheimer, Hans Lassmann, K. Kitz, Anthony P. Moran, William R. Levis, Michael Bach, T Berger, Harry C. Meeker, Eugene A. Sersen and Georgia Schuller‐Levis. Their work appears in journals such as Infection and Immunity, Journal of Neuroimmunology, Leprosy Review, Journal of Investigative Dermatology and Acta Neuropathologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.